Cipla wins R2bn state ARV tender

2014-12-23 16:04

Cipla Medpro has been awarded a R2-billion share of the government’s 2015-2017 national antiretrovirals tender.

Cipla chief executive Paul Miller said Cipla was proud to have been recognised as a preferred partner of the state in the fight against HIV and Aids.

“Cipla is known as a pioneer of fixed-dose combinations following Cipla’s Dr Yusuf Hamied’s accomplishment of making Aids medication available for a dollar a day in 2001,” he said.

Miller said Cipla went further and made the triple combination available in the world’s first 3-in-1 combination ARV.

“We intend to continue this proud tradition and build on the foundation laid to continue our quest of providing affordable health care to all.”

The contract was effective from April 1 2015 and would run for three years.

Cipla was the third-largest pharmaceutical company in South Africa.

Miller said this was the third government tender win in the last year for Cipla Medpro.

It won a R280-million state therapeutic drug tender in August and a R345-million national respiratory tender in June.

The medication would be produced at its state-of-the-art 23 000 square metre manufacturing facility, Cipla Medpro Manufacturing, in KwaZulu-Natal.

The facility employed about 300 staff members, 98% of whom were previously disadvantaged, he said.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.